Neurofilament accumulation disrupts autophagy in giant axonal neuropathy

被引:0
|
作者
Paumier, Jean-Michel [1 ]
Zewe, James [1 ]
Panja, Chiranjit [1 ]
Pergande, Melissa R. [1 ,4 ]
Venkatesan, Meghana [1 ]
Israeli, Eitan [1 ,5 ]
Prasad, Shikha [1 ]
Snider, Natasha [2 ]
Savas, Jeffrey N. [1 ]
Opal, Puneet [1 ,3 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol, Chicago, IL USA
[2] Univ North Carolina Chapel Hill, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC USA
[3] Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL USA
[4] Boston Univ, Dept Chem, Boston, MA USA
[5] Hebrew Univ Jerusalem, Fac Med, Hadassah Med Sch, Barry Skolnick Biosafety Level Unit 3, Jerusalem, Israel
关键词
PROTEIN; GIGAXONIN; MATURATION; CLEARANCE; LYSOSOMES; FAMILY;
D O I
10.1172/jci.insight.177999
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Neurofilament accumulation is associated with many neurodegenerative diseases, but it is the primary pathology in giant axonal neuropathy (GAN). This childhood-onset autosomal recessive disease is caused by loss-of-function mutations in gigaxonin, the E3 adaptor protein that enables neurofilament degradation. Using a combination of genetic and RNA interference approaches, we found that dorsal root ganglia from mice lacking gigaxonin have impaired autophagy and lysosomal degradation through 2 mechanisms. First, neurofilament accumulations interfere with the distribution of autophagic organelles, impairing their maturation and fusion with lysosomes. Second, the accumulations attract the chaperone 14-3-3, which is responsible for the proper localization of the key autophagy regulator transcription factor EB (TFEB). We propose that this dual disruption of autophagy contributes to the pathogenesis of other neurodegenerative diseases involving neurofilament accumulations.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] MELANOCYTIC INVOLVEMENT IN GIANT AXONAL NEUROPATHY
    BONERANDI, JJ
    GAMBARELLI, D
    HASSOUN, J
    PELLISSIER, JF
    TOGA, M
    JOURNAL OF CUTANEOUS PATHOLOGY, 1978, 5 (05) : 300 - 300
  • [42] GIANT AXONAL NEUROPATHY - A NEUROPATHOLOGICAL STUDY
    KRETZSCHMAR, HA
    BERG, BO
    DAVIS, RL
    ACTA NEUROPATHOLOGICA, 1987, 73 (02) : 138 - 144
  • [43] THE GIANT AXONAL NEUROPATHY - REPORT OF A CASE
    GUYOT, A
    JOANNARD, A
    VILA, A
    STOEBNER, P
    BEAUDOING, A
    PEDIATRIE, 1985, 40 (05): : 393 - 397
  • [44] PILAR CHANGES IN GIANT AXONAL NEUROPATHY
    LUGER, T
    GEBHART, W
    SLUGA, E
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1979, 106 (11): : 893 - 898
  • [45] Giant axonal neuropathy A clinicoradiopathologic diagnosis
    Israni, Anil
    Chakrabarty, Biswaroop
    Gulati, Sheffali
    Mohamed, Akbar
    Kumar, Atin
    Sable, Mukund N.
    Suri, Vaishali
    NEUROLOGY, 2014, 82 (09) : 816 - 817
  • [46] Phenotypic variability in giant axonal neuropathy
    Tazir, Meriem
    Nouioua, Sonia
    Magy, Laurent
    Huehne, Kathrin
    Assami, Salima
    Urtizberea, Andoni
    Grid, Djamel
    Hamadouche, Tarik
    Rautenstrauss, Bernd
    Vallat, Jean-Michel
    NEUROMUSCULAR DISORDERS, 2009, 19 (04) : 270 - 274
  • [47] TOXIC AXONAL DEGENERATION OCCURS INDEPENDENT OF NEUROFILAMENT ACCUMULATION
    SICKLES, DW
    PEARSON, JK
    BEALL, A
    TESTINO, A
    JOURNAL OF NEUROSCIENCE RESEARCH, 1994, 39 (03) : 347 - 354
  • [48] HETEROGENEITY OF AXONAL PATHOLOGY IN CHINESE PATIENTS WITH GIANT AXONAL NEUROPATHY
    Wang, Lu
    Zhao, Danhua
    Wang, Zhaoxia
    Zhang, Wei
    Lv, He
    Liu, Xiao
    Meng, Lingchao
    Yuan, Yun
    MUSCLE & NERVE, 2014, 50 (02) : 200 - 205
  • [49] AXONAL NEUROPATHY WITH MONOCLONAL IGG KAPPA THAT BINDS TO A NEUROFILAMENT PROTEIN
    NEMNI, R
    FELTRI, ML
    FAZIO, R
    QUATTRINI, A
    LORENZETTI, I
    CORBO, M
    CANAL, N
    ANNALS OF NEUROLOGY, 1990, 28 (03) : 361 - 364
  • [50] A PHOSPHORYLATED NEUROFILAMENT HEAVY CHAIN INDICATES THE SEVERITY OF AXONAL NEUROPATHY
    Chen, X-J
    Zhang, X. U.
    Xu, H.
    Zhu, D-Q
    Xi, Zhang
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2013, 18 : 22 - 22